Press release
Pancreatic Cancer Competitive Landscape Report (Updated) | Panbela Therapeutics, ERYtech Pharma, Jiangsu HengRui Medicine Co., Ltd., FibroGen, Novartis, AB Science, Astellas Pharma, AstraZeneca
Pancreatic Cancer Competitive Landscape
Key Takeaways from the Pancreatic Cancer Competitive Landscape Report
• DelveInsight's Pancreatic Cancer report depicts a robust space with 250+ Pancreatic Cancer companies working to develop 300+ pipeline therapies for Pancreatic Cancer treatment.
• The leading Pancreatic Cancer Companies working in the market include Panbela Therapeutics, ERYtech Pharma, Jiangsu HengRui Medicine Co., Ltd., FibroGen, Novartis AG, AB Science, TME Pharma AG, Intensity Therapeutics, Silenseed Ltd, SynerGene Therapeutics, Elevation oncology, Salspera LLC, Redx Pharma Plc, AIM ImmunoTech Inc., Rain Oncology, Jazz Pharmaceuticals, Invyte Corporation, Immodulon Therapeutics Ltd, GSK plc, Merck Sharp & Dohme LLC, Roche, Helsinn Healthcare SA, Argenus Inc., Actuate Therapeutics, OSE Immunotherapeutics, Incyte Corporation, Galera Therapeutics, CSPC ZhongQi Pharmaceutical Technology, Astellas Pharma Global Development, Inc., NanOlogy, Theriva Biologics, AstraZeneca, Berg LLC, Agenus, ABVC BioPharma, Inc., Boehringer Ingelheim, Alligator Bioscience, CARsgenTherapeutics Co. Ltd, Purple Biotech Ltd., Lisata Therapeutics, Chongqing Precision Biotech Co., Ltd, Cybrexa Therapeutics, Bold Therapeutics, BioNTech SE, Bristol-Myers Squibb, DEKA Biosciences, Senhwa Biosciences, Cue Biopharma, Carisma Therapeutics Inc., and others.
• Promising Pancreatic Cancer therapies in the various stages of development include Gemcitabine plus TS-1, Pegilodecakin, FOLFOX, Nanoplatin (NC-6004) and Gemcitabine, RP72, Demcizumab, Abraxane®, ACP-196, and others.
• December 2023: Processa Pharmaceuticals announced a study of Phase 1 clinical trials for RX-3117. This will be a Phase 1b/2a multicenter 2-stage study. Phase 1 will be conducted as a dose-finding, open-label study of oral RX-3117 administered in combination with Abraxane® to subjects with metastatic pancreatic cancer. After completion of the Phase 1 portion, a Phase 2a study will be conducted using a 2 stage, open-label design, of RX 3117 and Abraxane® in combination to treat subjects with metastatic pancreatic cancer as first line therapy.
• December 2023: Takara Bio Inc. announced a study of Phase 1 clinical trials for TBI-1401(HF10), Gemcitabine, Nab-paclitaxel and TS-1. The purpose of this study is to determine the recommended dose of TBI-1401(HF10) treatment in combination with chemotherapy (Gemcitabine + Nab-paclitaxel or TS-1) in patients with stage III or IV unresectable pancreatic cancer.
Request a sample and discover the recent advances in Pancreatic Cancer Drugs @ Pancreatic Cancer Competitive Landscape Report- https://www.delveinsight.com/report-store/pancreatic-cancer-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
The Pancreatic Cancer report provides in-depth commercial assessment of drugs that have been included, which comprises collaboration, agreement, licensing and acquisition - deals values trends. The sub-segmentation is described in the Pancreatic Cancer report which provide company-company collaboration (licensing/partnering), company academic collaboration and acquisition analysis in tabulated form.
Pancreatic Cancer Overview
Pancreatic cancer is a disease in which malignant or cancer cells form in the tissues of the pancreas. Pancreatic cancer begins in the tissues of the pancreas - an organ in the abdomen that lies behind the lower part of the stomach. Pancreatic cancer most frequently arises from pancreatic intraepithelial neoplasia (PanIN), the classic pre-neoplastic lesions, but can also arise from larger precursor lesions, namely, intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms.
Find out more about Pancreatic Cancer Analytical Perspective: In-depth Commercial Assessment @ Pancreatic Cancer Collaboration Analysis by Companies- https://www.delveinsight.com/sample-request/pancreatic-cancer-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Pancreatic Cancer Companies and Therapies
• Novartis AG: NIS793
• AB Science: Masitinib
• Panbela Therapeutics: SBP-101
• Intensity Therapeutics: INT230-6
• TME Pharma AG: Olaptesed Pegol
Pancreatic Cancer Competitive Landscape: Analytical Perspective
The Pancreatic Cancer report comprises of comparative assessment of Companies (by therapy, development stage, and technology).
Pancreatic Cancer Report Assessment
• Pancreatic Cancer Company Analysis
• Pancreatic Cancer Therapeutic Assessment
• Pancreatic Cancer Pipeline Assessment
• Inactive Pancreatic Cancer Drugs Assessment
• Pancreatic Cancer Unmet Needs
Learn more about the emerging Pancreatic Cancer Competitive Landscape @ Pancreatic Cancer Market Drivers and Barriers, Unmet Needs- https://www.delveinsight.com/sample-request/pancreatic-cancer-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Pancreatic Cancer Report
• Coverage- Global
• Pancreatic Cancer Companies- Panbela Therapeutics, ERYtech Pharma, Jiangsu HengRui Medicine Co., Ltd., FibroGen, Novartis AG, AB Science, TME Pharma AG, Intensity Therapeutics, Silenseed Ltd, SynerGene Therapeutics, Elevation oncology, Salspera LLC, Redx Pharma Plc, AIM ImmunoTech Inc., Rain Oncology, Jazz Pharmaceuticals, Invyte Corporation, Immodulon Therapeutics Ltd, GSK plc, Merck Sharp & Dohme LLC, Roche, Helsinn Healthcare SA, Argenus Inc., Actuate Therapeutics, OSE Immunotherapeutics, Incyte Corporation, Galera Therapeutics, CSPC ZhongQi Pharmaceutical Technology, Astellas Pharma Global Development, Inc., NanOlogy, Theriva Biologics, AstraZeneca, Berg LLC, Agenus, ABVC BioPharma, Inc., Boehringer Ingelheim, Alligator Bioscience, CARsgenTherapeutics Co. Ltd, Purple Biotech Ltd., Lisata Therapeutics, Chongqing Precision Biotech Co., Ltd, Cybrexa Therapeutics, Bold Therapeutics, BioNTech SE, Bristol-Myers Squibb, DEKA Biosciences, Senhwa Biosciences, Cue Biopharma, Carisma Therapeutics Inc., and others.
• Pancreatic Cancer therapies- Gemcitabine plus TS-1, Pegilodecakin, FOLFOX, Nanoplatin (NC-6004) and Gemcitabine, RP72, Demcizumab, Abraxane®, ACP-196, and others.
• Pancreatic Cancer Therapeutics Assessment- Product Type, Stage and Product Type, Route of Administration, Stage and Route of Administration, Molecule Type, Stage and Molecule Type
Dive deep into rich insights for new drugs for Pancreatic Cancer Product Developmental Activities, Visit @ Pancreatic Cancer Research and Development Activities- https://www.delveinsight.com/sample-request/pancreatic-cancer-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Pancreatic Cancer: Overview
4. Pancreatic Cancer-Analytical Perspective: In-depth Commercial Assessment
5. Pancreatic Cancer Competitive Landscape
6. Pancreatic Cancer Therapeutic Assessment
7. Pancreatic Cancer: Company and Product Profiles (Marketed Therapies)
8. Merck Sharp & Dohme LLC
9. Keytruda (pembrolizumab)
10. Pancreatic Cancer: Company and Product Profiles (Pipeline Therapies)
11. Late Stage Products (Phase III)
12. Novartis AG
13. NIS793
14. Drug profiles in the detailed report…..
15. Mid-Stage Products (Phase II)
16. AB Science
17. Masitinib
18. Drug profiles in the detailed report…..
19. Early Stage Products (Phase I)
20. Carisma Therapeutics Inc.
21. CT-0508
22. Drug profiles in the detailed report…..
23. Preclinical and Discovery Stage Products
24. TILT Biotherapeutics LLC
25. TILT-452
26. Drug profiles in the detailed report…..
27. Inactive Products
28. Pancreatic Cancer Unmet needs
29. Pancreatic Cancer Market drivers and barriers
30. Appendix
For further information on the Pancreatic Cancer Report @ Pancreatic Cancer Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/pancreatic-cancer-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Important Published Links
https://quantummemoir.mn.co/members/21285995
https://rightbusinesspath.mn.co/posts/48636294
https://tennispassion.mn.co/posts/48636354
https://king-business.mn.co/posts/48636411
https://forums.mbclub.co.uk/members/dennydones99.180319/#about
https://www.creativelive.com/student/dennydones1?via=accounts-freeform_2
https://tl.net/forum/profile.php?user=dennydones99
https://minne.com/@dennydones99/profile
https://network-79379.mn.co/members/20103624
https://ylimun.mn.co/members/20103614
https://kktix.com/user/5068280
https://network-373.mn.co/posts/48353213
https://body-imagine.mn.co/posts/48353364
https://pimpmyairgun.mn.co/posts/48353478
https://gtribe.mn.co/posts/advancements-and-opportunities-in-the-vulvar-cancer-market
https://communenour.mn.co/posts/emerging-trends-and-market-dynamics-in-vulvar-cancer-treatment
https://synkretic.mn.co/posts/understanding-the-vulvar-cancer-market-trends-challenges-and-innovations
https://jlfa2020.mn.co/members/16644457
https://dbook.mn.co/posts/48401881
https://lxgonline.mn.co/posts/navigating-the-landscape-of-hypertriglyceridemia-market-current-trends-and-future-prospects
https://www.penname.me/@dennydones99
https://community.fyers.in/member/7Yldtdsvui
https://spurstartup.mn.co/posts/48406045
https://pressurecooker.mn.co/posts/48406225
https://regenerative-future.mn.co/posts/navigating-the-hypertriglyceridemia-market-innovations-and-challenges
https://commiss.io/dennydones
https://www.pledgeme.co.nz/profiles/221820/
https://brave-comfort.mn.co/posts/48409148
https://gamebook.mn.co/posts/navigating-the-landscape-of-the-hypertriglyceridemia-market
https://biomolecula.ru/authors/25303
https://discuss.machform.com/u/dennydones9191
https://dagshub.com/dennydones9191
https://careerkarma.com/profile/clr7d7z0c04v2lf3k5lrx9vyr/
https://gotech.mn.co/posts/48477911
https://landmarknew.mn.co/posts/48477947
https://infiniteabundance.mn.co/posts/48478016
https://wellbeingmatters.mn.co/posts/48478424
https://vrjam.mn.co/posts/48478544
https://decidim.santcugat.cat/profiles/dennydones9/activity
https://haveagood.holiday/users/336105
https://participa.rubi.cat/profiles/dennydones9191/activity
https://forum.callofwar.com/index.php?user/60304-dennydones9191/#about
https://connectgalaxy.com/post/146081_syphilis-a-sexually-transmitted-bacterial-infection-caused-by-treponema-pallidum.html
https://www.thebostoncalendar.com/user/74833
https://wrongplanet.net/author/dennydones9999/
https://bookmark.hiauthors.com/story/syphilis-market
https://www.openhumans.org/member/anniethomas/
https://cynochat.com/read-blog/160375
https://hitrecord.org/users/dennydones9999/records
https://biiut.com/read-blog/918
https://nimmansocial.com/story5840956/syphilis-market
https://bookmarkbirth.com/story15878475/syphilis-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/stem-cell-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pancreatic Cancer Competitive Landscape Report (Updated) | Panbela Therapeutics, ERYtech Pharma, Jiangsu HengRui Medicine Co., Ltd., FibroGen, Novartis, AB Science, Astellas Pharma, AstraZeneca here
News-ID: 3350567 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Pancreatic
Growing Pancreatic Cancer Cases : Pivotal Factor Influencing Pancreatic Cancer D …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pancreatic Cancer Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for pancreatic cancer drugs has seen consistent growth over the past few years. An escalation from $3.96 billion in 2024 to $4.1 billion in 2025 is projected, marking a compound annual…
Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Pancreatic Cancer Diagnostic Market Through 2025?
The market size for pancreatic cancer diagnostics has been witnessing robust growth in recent times. There will be a growth from $4.24 billion in 2024 to $4.55 billion in 2025, showcasing a Compound Annual Growth Rate…
Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
The Pancreatic Cancer Diagnostic Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Pancreatic Cancer Diagnostic Market Size and Projected Growth Rate?
There has been a significant expansion in the pancreatic cancer diagnostic market recently. This market is projected to increase from a value…
Pancreatic Amylase Reagent Kits: Streamlining Enzyme Analysis for Efficient Panc …
Pancreatic Amylase Reagent Kits Market 2023 Forecast: Unveiling Opportunities and Growth
Pancreatic Amylase Reagent Kits Market research report helps to recognize the market challenges and opportunities. Global Pancreatic Amylase Reagent Kits Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of…
Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Panc …
Pancreatic cancer is one of the aggressive cancers that originate in the tissues of the pancreas and rapidly spreads to the nearby organs. Pancreatic cancer is the 12th most commonly occurring cancer in the world. According to the American Cancer Society, ~55,440 patients in the US are expected to be diagnosed with pancreatic cancer in 2018. Moreover, the ACS also reports that pancreatic cancer is the third leading cause of…
Pancreatic Cancer Treatment
Pancreatic Cancer Treatment Market describes its growth, size, share, Forecast and trends to 2025
Pancreatic Cancer Treatment Market Production and Demand Analysis 2019 to 2025
Pancreatic Cancer Treatment Market 2019 Manufacturing Analysis and Development Forecast 2025
Pancreatic Cancer Treatment Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Pancreatic Market to Insight By 2025: Top Key Vendors
Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to…
